VETERINARY SERVICES

View More

PHARMACY SERVICES

View More

Welcome to RamanPharma!

Raman Pharma is a UK based MHRA and VMD Licensed Wholesaler supplying to the Human and Veterinary Market. We are a family run company ambitiously changing the face of the Pharmaceutical and Veterinary Market alike in order to serve the needs of our customers and their patients.

Our Philosophy and business are structured around the requirements of our customers and we are committed to giving them our upmost attention and care. We believe in delivering quality and value to our customers wherever they may be.


Our UK and Ireland Products

The Herbal Horse and Pet is a South African manufacturer of a very innovative range of supplements for horses, dogs and cats. Their philosophy of using a large number of different ingredients in small amounts mimics nature in that the healing effect of the ingredients is maximised while undesirable side-effects are minimised. These unique formulations, in conjunction with 21st century scientific research and techniques are what they call “cutting edge nature”.

They are manufactured in a GMP Compliant Factory and has a large following from riders and pet owners across the world. Please follow the link to the website – www.theherbalhorse.co.uk to see all the amazing blogs and the ability to purchase these products online. The Equine and Pet Range were introduced to the UK Market in September 2014 by Raman Pharma to give the UK a taste of the future in equine and companion animal nutritional supplements.


Testimonials


Pharmacy News
  • Help fight C-19 by signposting patients to clinical studies
    Sunday, October 25, 2020 6:11 pm

    Community pharmacists and their teams are being encouraged to support the nation’s fight against COVID-19 by signposting patients with suspected or even confirmed SARS-COV-2 infection to the PRINCIPLE trial. The PRINCIPLE trial platform is a UK-wide priority trial to find treatments for COVID-19 and the only one based in primary care. It is designed to...

  • October 2020 Price Concessions 2nd Update
    Friday, October 23, 2020 3:01 pm

    Department of Health and Social Care (DHSC) has today granted the following list of price concessions: Drug  Pack Size Price Concession  Ciprofloxacin 250mg tablets 10 £1.37 Hydrocortisone 2.5% cream 15g £44.00 Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets 28 £14.31 Lamotrigine 50mg tablets 56 £3.31 Rasagiline 1mg tablets 28 £10.07 Tamoxifen 20mg tablets 30 £13.99 Zonisamide...

  • MHRA Drug Safety Update October 2020
    Friday, October 23, 2020 11:56 am

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 2 September 2020) has been published and includes articles on: 5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity Flucytosine (Ancotil): new contraindication in patients with DPD deficiency Niraparib...

  • SSPs issued for Fluoxetine 30mg caps & Salazopyrin EN-Tabs 500mg: Urgent actions required by pharmacy teams
    Wednesday, October 21, 2020 12:53 pm

    In response to significant ongoing disruption to the supply of Fluoxetine 30mg capsules and Salazopyrin® EN-Tabs 500mg, two Serious Shortage Protocols (SSPs) have been been issued by the Department of Health and Social Care (DHSC). Introduced with immediate effect today, Tuesday 20th October 2020, SSP07 has been developed by clinicians and provides pharmacists with procedures to...

  • Medicine Supply Notification: Ferrous Fumarate 322mg/Folic Acid 350mcg (Pregaday) tablets (Recipharm)
    Wednesday, October 21, 2020 12:24 pm

    Update 21/10/2020 Anticipated resupply date now late November 2020 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ferrous Fumarate 322mg/Folic Acid 350mcg (Pregaday) tablets (Recipharm) Pregaday tablets will be out of stock until October 2020. UKMI have provided clinical advice on switching to alternative iron and folic acid containing...

  • Medicine Supply Notification: Phytomenadione (Konakion MM Paediatric) 2mg/0.2ml ampoules (Cheplapharm) – Update
    Wednesday, October 21, 2020 12:22 pm

    Update – 21/10/2020 UK licensed Konakion MM Paediatric will be out of stock from the 1st – 30th November 2020 Supplies of Konakion MM Paediatric in tri-lingual packaging (including English; considered unlicensed in the UK) are available to support during this time. Department of Health and Social Care (DHSC) has issued a medicine supply notification for...

  • Medicine Supply Notification: Fluoxetine 30mg capsules (Advanz)
    Wednesday, October 21, 2020 11:42 am

    Department of Health and Social Care (DHSC) has today issued a medicine supply notification for Fluoxetine 30mg capsules (Advanz) Advanz, the sole supplier, are out of stock of fluoxetine 30mg capsules with resupply expected mid-December 2020 Fluoxetine 10mg and 20mg capsules remain available A Serious Shortage Protocol (SSP) was issued on 20/10/2020 further details can...

  • Medicine Supply Notification: Salazopyrin En-Tabs (sulfasalazine) 500mg tablets
    Wednesday, October 21, 2020 11:32 am

    Department of Health and Social Care (DHSC) has today issued a medicine supply notification for Salazopyrin En-Tabs (sulfasalazine) 500mg tablets Pfizer are out of stock of Salazopyrin En-Tabs until early December 2020 Generic versions of sulfasalazine 500mg gastro-resistant tablets remain available UKMI have advised there are no known differences in bioavailability between the branded and...

  • Serious Shortage Protocol (SSP): SSP08 – Salazopyrin® EN-Tabs 500mg
    Tuesday, October 20, 2020 3:12 pm

    In response to significant ongoing disruption to the supply of Salazopyrin® EN-Tabs 500mg, a Serious Shortage Protocol (SSP) have been issued by the Department of Health and Social Care (DHSC) and these can be accessed on the NHS Business Services Authority (NHSBSA) website. This briefing provides information on these SSPs and is intended as a...

  • Serious Shortage Protocol (SSP): SSP07 – Fluoxetine 30mg capsules
    Tuesday, October 20, 2020 3:12 pm

    In response to significant ongoing disruption to the supply of fluoxetine 30mg capsules, a Serious Shortage Protocol (SSP) have been issued by the Department of Health and Social Care (DHSC) and these can be accessed on the NHS Business Services Authority (NHSBSA) website. This briefing provides information on these SSPs and is intended as a...

MHRA Regulatory News
VMD Regulatory News
Global Pharmaceutical News

LOCATION

Unit 2 Fleet Business Park, Sandy Lane, Church Crookham, Fleet, Hampshire, GU52 8BF

INFORMATION

Pharmaceutical and Veterinary Licensed Distributor. WDA (H) 43703 & WDA (V) 43703.

CONTACT US

- +44 (0)1252 260 460.
- +44 (0)1276 469 290

OUR OPENING TIMES

Monday to Friday - 09:30 – 18:30
Saturday & Sunday - Closed, Online Ordering Available